MolRes-DTA: a molecular-multiview fusion and residue-aware model for drug-target affinity prediction
Open Access
- 10 April 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Digital Discovery
- Vol. 5 (5) , 2184-2194
Abstract
MolRes-DTA fuses drug and protein features for affinity prediction.Keywords
Funding Information
- National Natural Science Foundation of China (12404263)
This publication has 39 references indexed in Scilit:
- Drug–target affinity prediction using rotary encoding and information retention mechanismsEngineering Applications of Artificial Intelligence, 2025
- Drug–target binding affinity prediction model based on multi-scale diffusion and interactive learningExpert Systems with Applications, 2024
- A review of machine learning-based methods for predicting drug–target interactionsHealth Information Science and Systems, 2024
- GDilatedDTA: Graph dilation convolution strategy for drug target binding affinity predictionBiomedical Signal Processing and Control, 2024
- Drug–target affinity prediction method based on multi-scale information interaction and graph optimizationComputers in Biology and Medicine, 2023
- Deep learning in drug discovery: an integrative review and future challengesArtificial Intelligence Review, 2022
- Deep learning tools for advancing drug discovery and development3 Biotech, 2022
- Artificial intelligence in drug development: present status and future prospectsDrug Discovery Today, 2019
- Factors affecting drug absorption and distributionAnaesthesia & Intensive Care Medicine, 2017
- Receptor–ligand molecular dockingBiophysical Reviews, 2013